434 related articles for article (PubMed ID: 8735621)
1. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y
Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
[TBL] [Abstract][Full Text] [Related]
2. Central neuropeptide Y and the sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats.
Gué M; Yoneda M; Mönnikes H; Junien JL; Taché Y
Br J Pharmacol; 1992 Nov; 107(3):642-7. PubMed ID: 1472962
[TBL] [Abstract][Full Text] [Related]
3. Intracisternal PYY inhibits gastric lesions induced by ethanol in rats: role of PYY-preferring receptors?
Kawakubo K; Yang H; Taché Y
Brain Res; 2000 Jan; 854(1-2):30-4. PubMed ID: 10784103
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
[TBL] [Abstract][Full Text] [Related]
5. Spinal and peripheral modulation of gastric acid secretion and arterial pressure by neuropeptide Y, peptide YY, and pancreatic polypeptide in rats.
Wager-Pagé SA; Rosenbaum G; Veale WL; Davison JS
Peptides; 1993; 14(6):1299-308. PubMed ID: 8134313
[TBL] [Abstract][Full Text] [Related]
6. PYY-preferring receptor in the dorsal vagal complex and its involvement in PYY stimulation of gastric acid secretion in rats.
Yang H; Li WP; Reeve JR; Rivier J; Taché Y
Br J Pharmacol; 1998 Apr; 123(8):1549-54. PubMed ID: 9605560
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
8. In vitro steroidogenic effects of neuropeptide Y (NPY1-36), Y1 and Y2 receptor agonists (Leu31-Pro34 NPY, NPY18-36) and peptide YY (PYY) on rat adrenal capsule/zona glomerulosa.
Bernet F; Maubert E; Bernard J; Montel V; Dupouy JP
Regul Pept; 1994 Aug; 52(3):187-93. PubMed ID: 7800851
[TBL] [Abstract][Full Text] [Related]
9. Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo.
Souli A; Chariot J; Voisin T; Presset O; Tsocas A; Balasubramaniam A; Laburthe M; Rozé C
Peptides; 1997; 18(4):551-7. PubMed ID: 9210175
[TBL] [Abstract][Full Text] [Related]
10. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
Widdowson PS; Buckingham R; Williams G
Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
Haynes JM; Hill SJ; Selbie LA
Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
[TBL] [Abstract][Full Text] [Related]
12. Effects of neuropeptide Y and [Leu31,Pro34] neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat.
Penner SB; Smyth DD; Glavin GB
J Pharmacol Exp Ther; 1993 Jul; 266(1):339-43. PubMed ID: 8101219
[TBL] [Abstract][Full Text] [Related]
13. PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC.
Chen CH; Stephens RL; Rogers RC
Neurogastroenterol Motil; 1997 Jun; 9(2):109-16. PubMed ID: 9198086
[TBL] [Abstract][Full Text] [Related]
14. Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type.
Dumont Y; Cadieux A; Pheng LH; Fournier A; St-Pierre S; Quirion R
Brain Res Mol Brain Res; 1994 Oct; 26(1-2):320-4. PubMed ID: 7854062
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of neurons in rat ARC inhibits gastric acid secretion via hypothalamic CRF1/2- and NPY-Y1 receptors.
Tebbe JJ; Mronga S; Schäfer MK; Rüter J; Kobelt P; Mönnikes H
Am J Physiol Gastrointest Liver Physiol; 2003 Dec; 285(6):G1075-83. PubMed ID: 12855401
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of canine exocrine pancreatic secretion by peptide YY is mediated by PYY-preferring Y2 receptors.
Teyssen S; Grandt D; Niebergall-Roth E; Schimiczek M; Goebell H; Eysselein VE; Reeve JR; Singer MV
Pancreas; 1996 Jul; 13(1):80-8. PubMed ID: 8783338
[TBL] [Abstract][Full Text] [Related]
17. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells.
Grundemar L; Håkanson R
Br J Pharmacol; 1991 Dec; 104(4):776-8. PubMed ID: 1725763
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.
Monnet FP; Fournier A; Debonnel G; de Montigny C
J Pharmacol Exp Ther; 1992 Dec; 263(3):1212-8. PubMed ID: 1469629
[TBL] [Abstract][Full Text] [Related]
20. Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain.
Widdowson PS
Brain Res; 1993 Dec; 631(1):27-38. PubMed ID: 8298993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
